Global Blood Transfusion Diagnostics Market - Strategic Insights and Forecasts (2025-2030)

The Global Blood Transfusion Diagnostics Market is projected to grow significantly, expanding from USD 4.48 billion in 2025 to USD 6.77 billion by 2030. This growth is anticipated at a robust Compound Annual Growth Rate (CAGR) of 8.59% over the forecast period.

The market's growth is primarily driven by the escalating burden of chronic disorders like anemia and CKD, which increase the need for blood transfusions. Additionally, the rising incidence of trauma, car accidents, and surgical procedures, along with the critical need for comprehensive donor screening, are significant growth factors.

North America is projected to be the largest regional market for global blood transfusion diagnostics from 2025 to 2030. This dominance is attributed to increased public awareness regarding blood donations, high acceptance of blood transfusion procedures, and a well-developed healthcare infrastructure.

The market is significantly shaped by the emergence of advanced molecular platforms, which are accelerating the shift from manual testing to semi-automated and fully automated devices. These automated systems are critical for accurately detecting transfusion-transmissible infections (TTIs) and minimizing human error during the transfusion procedure.

The report provides a comprehensive analysis segmented by Type (Instruments, Kits & Reagents), by Technology (ELISA, Western Blotting, Nucleic Acid Amplification, Others), by End-User (Hospitals And Clinics, Diagnostic Labs, Blood Banks), and by Geography. This detailed breakdown offers a granular view of market opportunities and trends.

Despite challenges like limited blood supply and inadequate infrastructure, developing and underdeveloped countries present significant opportunities for market growth. Addressing the lack of proper blood banks, medical equipment, and suitable storage conditions can expand access to essential blood transfusion diagnostics and services.